Rising Regulations And Oversupply Will Weigh On Margins In Chemicals

AnalystLowTarget

Not Invested

Consensus Narrative from 16 Analysts

Published

18 Apr 25

Updated

20 Aug 25

AnalystLowTarget's Fair Value

US$40.00

17.7% overvalued

20 Aug

US$47.09

-64.1%

4.1%

-64.1%

4.1%

Author's Valuation

US$40.0

17.7% overvalued

AnalystLowTarget Fair Value

Narrative

Updates1

Shared on07 May 25
Fair value Decreased 15%

AnalystLowTarget Fair Value

US$40.0

17.7% overvalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

1.73%

Chemicals revenue growth rate

0.36%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

12.32%

Calculation

US$912.72m

Earnings '28

6.83x

PE Ratio '28

US$6.23b

Market Cap '28

US$6.23b

Market Cap '28

110.08m

No. shares '28

US$56.64

Share Price '28

US$56.64 Share Price '28

Discounted to 2025 @ 12.32% p.a.

US$39.97

Fair Value '25

Rising Regulations And Oversupply Will Weigh On Margins In Chemicals

Shared on07 May 25Fair value Decreased 15%

Shared on07 May 25
Fair value Decreased 15%